Basilea Pharmaceutica AG (LON:0QNA)
London
· Delayed Price · Currency is GBP · Price in CHF 47.35
-0.75 (-1.56%)
At close: Jun 27, 2025
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 528.64 million as of June 30, 2025. Its market cap has increased by 20.67% in one year.
Market Cap
528.64M
Enterprise Value
520.34M
Revenue
183.82M
Ranking
n/a
PE Ratio
7.73
Stock Price
47.35
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 231.10M to 528.64M, an increase of 128.75%. That is a compound annual growth rate of 3.97%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 156.93B |
| GSK plc | 56.25B |
| Haleon | 33.64B |
| Smith & Nephew | 9.74B |
| ConvaTec Group | 5.90B |
| Hikma Pharmaceuticals | 4.38B |
| HUTCHMED (China) | 1.87B |
| Indivior | 1.35B |